May 11 2005
Veenendaal, The Netherlands,- Nucletron Corporation, the Sales and Services subsidiary of Nucletron B.V. and responsible for the North and South American markets, has appointed Paul Schilstra as Director of Software, specifically Director of Oncentra™. Mr. Schilstra will report to John C. (Jack) Coats, president of Nucletron Corporation Inc. “We are pleased to have Paul Schilstra join our management team and bring new focus to our Oncentra Software Solutions business,” said Mr. Coats. “With the recent release of Nucletron’s exciting new software products, Oncentra MasterPlan and Oncentra Optimizer, Nucletron is poised for growth in IMRT treatment planning. Mr. Schilstra’s experience in clinical process improvement will provide the right leadership to our Oncentra Information Management Solutions business as well,” continued Mr. Coats. Paul Schilstra has more than twenty years of domestic and international experience in the healthcare information technology industry. Most recently, Mr. Schilstra was a Senior Director at Siemens Medical Solutions Health Services (previously known as Shared Medical Systems before the acquisition by Siemens in 2000) with worldwide responsibility for the Enterprise Document & Health Information Management solutions. Prior to that, Mr. Schilstra was responsible for International Business Development at Siemens Medical Solutions Health Services. Before the acquisition by Siemens in 2000, Mr. Schilstra served as a Senior Consulting Manager in the Strategic Services Group of Shared Medical Systems. In this capacity, he was responsible for numerous consulting projects in clinical process improvement, revenue cycle optimization, and information technology. Mr. Schilstra holds a Masters and a Bachelors degree in Industrial Engineering and Management Science from the Eindhoven University of Technology in the Netherlands. About Nucletron B.V. Nucletron is a global leader in the development, manufacture, sales, service and support of the world’s most innovative products for cancer treatment, with particular expertise in treatment planning systems, brachytherapy, simulation, integrated software solutions for oncology, and comprehensive support and professional education and services. The company has over 20 offices worldwide, including its corporate headquarters in Veenendaal, the Netherlands. For more information on Nucletron, please visit: https://www.nucletron.com/. Nucletron B.V. is a subsidiary of Delft Instruments. Delft Instruments is the holding company of an international group of companies, which hold a leading position in their respective markets with high quality, high technology products and services. Delft Instruments is active through wholly owned subsidiaries in more than 30 countries worldwide, employs approximately 1,000 people and reported turnover of EUR 261.6 million in 2004. For more information on Delft Instruments, please visit: http://www.delftinstruments.com/. For further information: